© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Scientists spent years tackling respiratory diseases in livestock before a solution like tulathromycin arrived. Decades ago, cattle and swine producers faced major losses from bacterial lung infections. Treatments often struggled with resistance or just didn't stick around in an animal's system long enough. Researchers at the turn of the millennium, fueled by mounting frustration over treatment gaps and rising demand for healthier herds, started looking for new classes of antibiotics. Their efforts led to the macrolide family, where tulathromycin made its mark by offering broad and long-lasting bacterial action. Introduced commercially in the early 2000s, its impact spread quickly, bringing hope to veterinarians tired of chasing infections with short-lived drugs.
Tulathromycin stands out as a semi-synthetic macrolide antibiotic tailored for veterinary use, specifically addressing respiratory infections in cattle, swine, and sheep. Unlike older macrolides, tulathromycin features a unique triamilide structure, acquired through chemical modification, which gives it a wider reach against key pathogens like Mannheimia haemolytica, Pasteurella multocida, and Mycoplasma bovis. Available most commonly as a sterile injectable solution, it has changed how farms and veterinarians respond to outbreaks. Its ability to maintain therapeutic concentrations in target tissues for days after a single administration brings obvious practical benefits in large animal management.
People sometimes overlook the hands-on chemistry behind animal medicines. Tulathromycin appears as a white to off-white powder, moderately soluble in water, heavier in organic solvents. Its molecular weight crosses 800 g/mol—a hefty structure for an antibiotic. The compound carries three amine groups, which make it a ‘triamilide’ rather than a typical 14- or 15-membered macrolide. Its stable structure allows it to resist breakdown by common enzymes produced by bacteria, which partly explains its effectiveness in hard-to-treat infections.
If you read a tulathromycin vial, you’ll spot specific dosing instructions reflecting large-scale safety and efficiency studies. The dose tends to fall around 2.5 mg/kg body weight in cattle and 2.5 mg/kg in swine. Labels warn against use in humans and highlight withdrawal periods to keep residues out of the food chain, a nod to rising public concern over antibiotic carryover into meat and milk. Regulatory bodies like FDA and EMA scrutinize these details before the drug lands in the marketplace, requiring a pile of animal and tissue studies. You’ll also find directions to protect the solution from heat and light, since some macrolides degrade quickly in rough storage.
Real innovation appeared in the chemical process behind tulathromycin. Chemists begin with clarithromycin, a relative of erythromycin, then push it through multiple steps—alkylation, reductive amination, and selective protection and deprotection—to introduce its distinctive amine groups. Unlike early antibiotics, produced directly by fermentation, tulathromycin depends on a carefully designed synthesis route, coupling traditional fermenters with modern organic chemistry. This mix keeps impurities low and batch quality high, which veterinarians and farmers count on for predictable results.
Scientists keep a close watch on tulathromycin's chemical behavior because bacteria adjust over time. Laboratories test various derivatives and analogs, tweaking functional groups to beat down new forms of bacterial resistance. Some research explores combining tulathromycin with anti-inflammatory agents or other antibiotics, aiming to broaden its usefulness or help animals heal faster. The structure’s flexibility offers a hunting ground for future antibiotics, especially as global regulators press for better stewardship of animal medicines.
You won’t only see ‘tulathromycin’ on the shelf. Brand names like Draxxin dominate in North America and Europe, with generics entering the market as patents expire. The chemical sometimes appears under trade numbers or lab codes in research, referencing its full chemical name: 13-deoxo-9,12-di(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-oxo-1-oxa-6-azacyclopentadecan-15-one. While that’s a mouthful, veterinarians and farmers know it as the go-to for tough bovine pneumonia.
Every medicine demands respect from those who use it. Tulathromycin, like most veterinary antibiotics, can trigger allergic reactions in people with macrolide sensitivities. The bottles and safety data sheets flag this plainly. Field veterinarians wear gloves, avoid accidental self-injection, and store it out of reach of food and drink. Clear records of treated animals matter for herd health management and food safety audits alike. I remember working on a midwestern feedlot years ago—managers drilled safety into every new hand, aware that a careless injection could land someone in the emergency room, or worse, send tainted meat to market. The standards grow stricter year by year as European and American agencies update their codes in step with emerging science.
Animal agriculture is no stranger to respiratory disease—bacterial pneumonia kills or weakens calves, yearlings, and finishing pigs across the globe. Tulathromycin steps in where older drugs start to falter, especially in mixed infections or crowded feedlots. It finds a place in metaphylaxis programs, where healthy-appearing animals receive a preventive dose before an outbreak spreads. This approach, controversial in some circles, reflects a hard trade-off between food production and concerns over resistance. In my years working with producers, I’ve seen whole outbreaks shut down by timely tulathromycin use, saving hundreds of animals and thousands of dollars in losses.
The research pipeline doesn’t rest, even on established drugs. Scientists around the globe keep tracking tulathromycin’s changing battlefield: new bacterial strains, new co-infections, changes in animal transport and housing. Some studies focus on its distribution and persistence in muscle, lung, and even milk, answering calls for more precise withdrawal times and improved safety margins. Others dig into the immune effects of tulathromycin, with early results hinting that the drug, beyond killing bacteria, might modulate cattle and pig immune responses for better recovery. The rush to publish new methods of synthesis or improved derivatives keeps academic and company labs busy, especially as generic manufacturers angle for a share of a lucrative market.
Every drug comes with risk, and tulathromycin is no exception. Animal studies, public data, and regulatory reviews all point toward a generally favorable safety profile at recommended doses. Overdoses in cattle and swine, sometimes seen in rushed mass treatments, can lead to swelling or mild fever; extremely high doses risk organ stress. The withdrawal periods for meat and milk, rooted in years of monitoring, protect consumers while giving farmers practical timelines for marketing. Veterinary schools teach careful record-keeping for each dose, since regulatory agencies regularly audit food animal producers. As resistance worries grow, more studies dig into subtle effects—on gut flora, on immune markers, and whether long-term or widespread use could cause new health concerns.
Looking ahead, tulathromycin faces a world of shifting expectations. Producers, consumers, and regulators push for fewer antibiotics in the food chain, and old tactics fade. Research pushes toward more targeted treatments, improved diagnostics, and alternatives like vaccines or probiotics. Tulathromycin’s continued usefulness depends on judicious stewardship and honest risk communication, both to livestock producers and the public. The past twenty years turned it from a fresh lab discovery into a standard tool in the field. Staying ahead will take the same blend of sharp science, common sense, and respect for the deep connections between animal and public health.
Raising livestock throws plenty of challenges at farmers, from feeding prices to weather headaches. Diseases can hit a herd hard, turning a healthy pen into a group of weak animals. Tulathromycin stands out in the fight against respiratory disease in cattle, swine, and sheep. Farmers and veterinarians trust this antibiotic for a reason: it helps sick animals recover faster and keeps healthy ones on track.
Bovine respiratory disease complex knocks young cattle sideways. In a feedlot, animals shipped in from ranches carry stress and germs. Bacteria like Mannheimia haemolytica and Pasteurella multocida invade their lungs. Cattle cough, lose appetite, and get fevers. Respiratory disease often leads to death if not treated quickly. For food producers, that means lost income and wasted resources.
Tulathromycin gives veterinarians an important tool. Unlike older medicines that require repeated injections, tulathromycin usually calls for a single dose. This makes a difference for animal stress and for people handling big groups of animals. My own experience with a cow-calf operation showed me the stress of rounding up calves for shots every other day. With tulathromycin, animals spend less time in the chute and more time eating, which shows up in the weight they gain.
Pigs face their own version of respiratory disease in nursery and grow-finish barns. Actinobacillus pleuropneumoniae causes outbreaks that can wipe out entire pens. Tulathromycin shifts the odds. Instead of running through a barn every morning to treat sick pens over and over, a veterinarian can control an outbreak with less handling. That’s a clear boost for animal well-being.
Sheep, too, deal with pneumonia especially after stressful weaning or weather swings. Sick lambs look dull and drop behind the flock. Tulathromycin offers a solution that supports flock health without a heavy workload.
Antibiotics carry responsibility. The world watches closely how agriculture uses medicines. Tulathromycin only works if used correctly—at the right dose, for the right illness, and with respect for withdrawal times. Farmland must protect both animal and human health. The Centers for Disease Control and Prevention warns about antibiotic resistance, so every injection needs careful thought.
Veterinarians turn to diagnostic tests and herd history before reaching for tulathromycin. It isn’t meant to replace good management—clean pens, low-stress handling, and vaccinations all reduce the need for medicine. Still, when the situation calls for antibiotics, using a single-shot drug that targets the lungs helps restore health while cutting down on overall use. That’s a win for producers, animals, and food safety.
Farmers share a goal: healthy animals. Tulathromycin remains a cornerstone in the toolkit because it targets the right bugs and gives animals a fair shot at recovery. From keeping cattle growing strong to avoiding pig losses in a barn, it plays a key part in today’s animal agriculture. Used wisely, it helps families across the countryside raise food that keeps shelves stocked and tables full.
Tulathromycin is one of those tools that people working with cattle, swine, and sheep won’t want to overlook. You find it at the core of treatment plans for a range of respiratory diseases. The drug hits bacteria where it hurts, bringing sick animals back from the brink. The big question becomes: how do you actually get this antibiotic into the animal? Delivery has to be spot-on, or the medicine doesn’t get a fair chance to work—or worse, risks harm.
I’ve spent plenty of time off my boots in pens and on pasture managing shots for livestock. Tulathromycin comes in a liquid form designed for injection, and for good reason. Oral dosing, in this case, just doesn’t cut it. Cattle have ruminant stomachs that’d break down most antibiotics before they get into the bloodstream. Swine and sheep also respond best to injection when you’re fighting an aggressive bug like Mannheimia haemolytica or Pasteurella multocida.
Careful technique matters. Tulathromycin only works as intended when it’s injected beneath the skin—subcutaneously. This isn’t just a clinical preference; it’s what the label lays out. The best site sits on the loose skin in front of the shoulder. Injection here causes less stress and tissue damage. I learned as a junior hand that needles for calves usually run 16 or 18 gauge, about an inch long; for full-grown animals, that needle might go up to an inch and a half. Always using a new, sharp needle minimizes injury and keeps contaminants from riding in with the drug.
Dosing follows weight, not guesswork. Package inserts—checked and rechecked by veterinarians—spell out the mg per kg, and it pays to stick with them. Too little tulathromycin lets infection win; too much risks lingering traces in the meat, which lands everyone in trouble. Animals go through withdrawal periods after shots, meaning you wait a set number of days before sending them for slaughter. That’s public health in action, not just paperwork.
One major problem springs up often: improper technique. Every stockman has met someone who skips steps, injecting into muscle or missing the loose skin entirely. That causes soreness or, in some cases, scarring. Education solves this—so does taking six seconds to check your work and train hands rather than cut corners. Another persistent issue comes from guessing weights or using faulty scales. Judging by eye cheats both the animal and the farmer. I always insist on weighing. It saves dollars on wasted medicine and betters the odds for recovery.
Antibiotics never come as a one-size-fits-all answer. As resistance creeps up, some fixes need a hard look at the whole system: smarter record-keeping, only treating symptomatic animals, and using alternatives in mild cases. Vets guide dosage, technique, and tough decisions about whether tulathromycin should even be the go-to drug. That relationship does more to keep antibiotics useful than anything else I've seen. Tulathromycin proves lifesaving in many barns, but it’s only one chapter in a much bigger book on herd health—best written with care and respect for both animals and people down the line.
Tulathromycin stands out in veterinary medicine, especially for fighting respiratory diseases in cattle and pigs. Vets and farmers often trust it because it handles tough bacteria when animals fall sick. Still, any medicine brings a risk of side effects, so knowing what could happen matters a lot before anyone uses it in the barn or pasture.
Most animals recover after a dose, but sometimes things go off track. Swelling or soreness at the injection site crops up pretty often. I've watched calves twitch and stomp after getting a shot, clearly annoyed by aches in their muscles. Usually, this tenderness fades within a couple days, but the sight can worry someone new to the farm.
Digestive troubles follow in some cases. A rancher shared how his stock would eat less the day after a shot, or come up with bouts of soft manure. It passes after a short time, but any dip in appetite gets noticed fast in growing animals. Reports also mention some animals acting sluggish, almost as if they’d rather nap than graze. This kind of tiredness often passes, too, but it’s a reminder that animal bodies can react in unpredictable ways.
Most stories stick to swelling and belly issues, but vets keep their eyes open for rare reactions. Fast or irregular breathing might show up, especially if a calf already has breathing troubles before the injection. On rare occasions, animals can collapse or develop life-threatening reactions — severe allergic responses marked by hives, trouble breathing, or shock. In large herds treated together, deaths have occasionally been reported, mostly in young calves and pigs, though these cases remain rare.
Side effects call for real attention, not just flipping through a drug label. Tulathromycin belongs to the macrolide class, medicines often chosen when animals face life-or-death infections. Overusing antibiotics can build up resistance, which puts both animal and human health at risk. I’ve heard people shrug off swollen necks or slower eating as “just part of the job,” but these signs deserve a closer look. Reporting issues to a veterinarian, or even to the manufacturer, helps keep future animals safe.
Careful dosing brings real results. Sticking to the proper route of injection (under the skin, never in muscle) can lower pain and swelling. Using clean needles for every animal pays off by cutting down on infections. Farmers I’ve worked alongside keep logs—tracking which animal, what dose, and how the animal feels after. This habit can flag problems before they spread too far.
Vets encourage giving animals a break from stress before and after vaccination or treatment. Calm handling helps a lot. Watching animals closely for a few hours after a shot uncovers side effects early, and shows respect for the well-being of each creature in the herd.
Tulathromycin can mean the difference between life and death in cattle or pigs facing respiratory disease. Owners balance risks with real benefits. Awareness of side effects, even if most are mild, protects animal health and keeps food supplies safer for everyone. Staying informed and keeping in close touch with veterinarians remains the best way to handle these challenges on the farm.
Tulathromycin’s strongest reputation rests on its use in cattle and swine. Anyone who has worked on a farm or spent time in a veterinary clinic probably recognizes it by its trade names like Draxxin. This antibiotic brings real relief in outbreaks of respiratory disease, especially during seasons when conditions crowd animals together. Reputable health sources, including the FDA and European Medicines Agency, stick by tulathromycin’s safety and effectiveness in these specific animals. Claims have been well backed by studies showing reduced mortality and faster recovery in herds hit by tough bacterial culprits.
Cattle face persistent threats from pathogens like Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni. Tulathromycin targets these offenders, making it a preferred tool for veterinarians who value single-dose treatments. People who have handled coughing calves in a feedlot during late autumn storms know the value of medicine that acts quickly and lasts long enough to avoid another stressful injection round. For pigs, Actinobacillus pleuropneumoniae and Mycoplasma hyopneumoniae can threaten entire barns. Tulathromycin’s track record for swine respiratory disease is supported by both lab testing and field results across North America, Europe, and Australia.
The label doesn’t include horses, sheep, goats, poultry, or household pets. Some folks search for off-label shortcuts, thinking one antibiotic can solve a barn’s entire lineup of health woes. This habit creates risks for animals and owners. Horses react badly to tulathromycin; injections can kick off dangerous inflammation and pain. Dogs and cats face even greater risks, with no real safety benchmarks and potential for severe illness.
Regulators stay clear on this for a reason. Tulathromycin’s withdrawal times in food animals help keep drug residues out of human meals. No one wants to think about antibiotic-tainted steaks or pork chops. Using it in species that haven’t been approved opens the door for unsafe meat reaching the kitchen table, damages public trust in food safety, and can cause unexpected reactions in the animals treated. Anyone who has felt the sting of a drug recall or worked through a farm audit knows these headaches eat into everyone’s time and break confidence between farmers, vets, and consumers.
Over the years, I have seen how eager people get when a new medicine works. A dairy farmer may ask if tulathromycin could help a sick goat or sheep in their flock based on success with their calves. It pays to explain why species matter. Goats and sheep metabolize drugs differently, and there’s no safety guarantee without studies. Encouraging thorough conversations with veterinarians ensures animals get the right medicine by weight, species, and infection type, while also protecting future treatment options for everyone. Experts remind us that antibiotics used wrongly speed up resistance, making it harder to tackle illness down the road.
Sustainable animal health starts with using tools as intended. The veterinary field depends on trust—between science, farming traditions, and the everyday workers who keep livestock healthy. New antibiotic guidelines keep changing, but the lesson hasn’t shifted: use tulathromycin for cattle and pigs, not for all creatures on the farm. This way, herds recover faster, food stays dependable, and valuable drugs stay available for future generations. Our daily choices shape both animal welfare and the bigger picture of food safety, and sticking to evidence makes that job a whole lot stronger.
Taking care of food safety means respecting the rules set around drug residues. Tulathromycin, often recognized by its trade name Draxxin, gets used a lot by veterinarians and farmers to treat respiratory diseases in cattle, pigs, and sometimes sheep. There’s comfort in having effective treatments for animals, but there’s also real risk if traces of the drug linger in meat or milk that people eat and drink. That’s where the withdrawal period enters the picture.
Clear withdrawal intervals for tulathromycin have been drawn up after plenty of testing and regulatory debates. In beef and non-lactating dairy cattle, the minimum waiting time runs 18 days after injection. For swine, that period shortens to 5 days. Lactating dairy cows and any animal destined for immediate slaughter within the withdrawal timeframe shouldn’t get tulathromycin, full stop. Sheep, when approved locally, typically require at least 16 days—always check updates from local authorities. Following these times means the medicine has naturally broken down enough inside the animal, letting residue drop below safe limits.
In my experience growing up on a mixed farm, applying these withdrawal guidelines always took discipline. We color-coded treatment records, hung calendars near the feeding pens, and checked them before loading animals for market. Missing one dose date could mean trouble—not just for the food chain, but for legal fallout and farmer trust. I’ve watched how careful recordkeeping really makes or breaks drug traceability. Sometimes, staff turnover or sheer workload can tempt shortcuts, but it’s just not worth the risk.
The numbers set by the U.S. Food and Drug Administration, European Medicines Agency, and similar agencies worldwide reflect hard-won consensus after reviewing hundreds of studies. Tulathromycin breakdown rates hinge on the animal’s age, health, and how quickly tissue turns over. A calf fighting a heavy infection processes medicine more slowly than a healthy steer. Slaughtering or milking before the withdrawal period fully passes could leave too much residue—triggering recalls, damaging export trust, and breaking public confidence.
Enforcement often starts with random residue tests at processors. Nobody enjoys surprise visits or paperwork, but every time a batch fails residue checks, trust takes another hit. On the positive side, digital record apps have started replacing notebooks in the barn. They send reminders before the withdrawal ends and flag if a treated animal is scheduled for slaughter too soon. That’s a move in the right direction. Having a clear talk with vets about what's being used and why removes confusion and helps everyone stay on the same page.
The thing about withdrawal times is they really depend on teamwork—farmers, vets, processors, and regulators all play their part. Biomedical science can set recommendations, but human honesty and practical routines make those recommendations real in daily work. Streamlining drug inventory, honest documentation, and ongoing reminders transform these technical details into lasting food safety. Consumers want confidence that their meals come from animals raised with care. If everyone in the chain treats withdrawal periods as non-negotiable, not just a regulatory box to tick, we all win—safer food, fair trade, and better trust between farm and table.
| Names | |
| Preferred IUPAC name | (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[[2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one |
| Other names |
Draxxin Tulissin Tulaven Increxxa |
| Pronunciation | /tuː.ləˈθrɒm.ɪ.sɪn/ |
| Identifiers | |
| CAS Number | 217500-96-4 |
| Beilstein Reference | 12194882 |
| ChEBI | CHEBI:90219 |
| ChEMBL | CHEMBL1201197 |
| ChemSpider | 16213111 |
| DrugBank | DB06457 |
| ECHA InfoCard | 14c5eaa3-744d-4aee-98c5-ae03be134267 |
| EC Number | EC 3.1.1.- |
| Gmelin Reference | 119287 |
| KEGG | D06423 |
| MeSH | D000068878 |
| PubChem CID | 11444916 |
| RTECS number | XR76Y6O27A |
| UNII | 7FR2RAL33M |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | DTXSID7021151 |
| Properties | |
| Chemical formula | C41H79N3O12 |
| Molar mass | 806.1 g/mol |
| Appearance | Clear, colorless to slightly yellowish solution |
| Odor | Faintly aromatic |
| Density | 1.03 g/cm³ |
| Solubility in water | Soluble in water |
| log P | 3.69 |
| Acidity (pKa) | 7.7 |
| Basicity (pKb) | 8.45 |
| Dipole moment | 2.52 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 370.6 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | J01FA94 |
| Hazards | |
| Main hazards | May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHSS |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| Precautionary statements | Keep out of reach of children. For animal treatment only. |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 1, Instability: 0, Special: |
| Lethal dose or concentration | LD50 (rats, oral): >5000 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Tulathromycin: **> 3000 mg/kg (rat, oral)** |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Tulathromycin: Not established |
| REL (Recommended) | 3 mg/kg bw |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Azithromycin Clarithromycin Erythromycin Tilmicosin Tylosin |
